-
Sector Analysis
Polycystic Ovarian Syndrome (PCOS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Polycystic Ovarian Syndrome (PCOS) Marketed and Pipeline Drugs Report Overview Polycystic Ovarian Syndrome (PCOS) is a complex condition characterized by elevated androgen levels, menstrual irregularities, and/or small cysts on one or both ovaries. It stands as the most prevalent hormonal disorder affecting females of reproductive age. Genetic and environmental factors are responsible for the etiology of this condition. Unhealthy lifestyle choices, dietary habits, or exposure to infectious agents tend to increase the risk of developing PCOS. Key Mechanisms of Action...
-
Sector Analysis
Female Sexual Dysfunction (FSD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Female Sexual Dysfunction (FSD) Marketed and Pipeline Drugs Report Overview Female sexual dysfunction (FSD) is an umbrella term that encompasses disorders of sexual desire, orgasm, arousal, and sexual pain that result in significant personal distress. FSD is a multifactorial, progressive problem that can occur at any stage of life. It is a complex neurovascular phenomenon that is under the control of psychological, neurovascular, and hormonal factors. Key Mechanisms of Action (Marketed) · Receptor Agonist · Enzyme Inhibitor · Receptor Antagonist...
-
Product Insights
Endometriosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Endometriosis Clinical Trial Report Overview A total of 812 Endometriosis clinical trials were conducted as of February 2024. The Endometriosis clinical trial report provides a comprehensive understanding of the Endometriosis clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions · North America · Europe · Asia-Pacific · ...
-
Sector Analysis
Premature Labor (PL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Premature Labor (PL) Marketed and Pipeline Drugs Report Overview Premature/preterm labor (PL) is labor occurring after 20 and before 37 weeks gestation. Premature deliveries cause more than half of long-term morbidity and 75% of perinatal mortality. Premature labor is diagnosed primarily by history and symptoms. Symptoms of preterm labor include regular contractions before term gestational age associated with cervical change, pelvic pressure, menstrual-like cramps, watery vaginal discharge, and lower back pain. Although lower back pain is present in normal pregnancy as well,...
-
Product Insights
NewOvarian Disease – Drugs In Development, 2024
Empower your strategies with our Ovarian Disease – Drugs In Development, 2024 report and make more profitable business decisions. Ovarian disease is a term for various conditions that affect the ovaries, which are the female reproductive organs that produce eggs and hormones. The most common ovarian diseases include polycystic ovary syndrome (PCOS), a hormonal disorder that causes irregular periods, excess androgen, and multiple cysts on the ovaries. PCOS can affect fertility and increase the risk of diabetes and heart disease. Another...
-
Product Insights
NewCervical Intraepithelial Neoplasia (CIN) – Drugs In Development, 2024
Empower your strategies with our Cervical Intraepithelial Neoplasia (CIN) – Drugs In Development, 2024 report and make more profitable business decisions. Cervical intraepithelial neoplasia (CIN), also known as cervical dysplasia, is characterized by the abnormal appearance of cells on the surface of the cervix. Cervical dysplasia usually occurs in women ages 25 to 35. Most cases of cervical dysplasia are caused by human papillomavirus (HPV). Factors contributing to cervical dysplasia include using immunosuppressants and smoking. Signs and symptoms include genital warts,...
-
Product Insights
NewFemale Sexual Dysfunction – Drugs In Development, 2024
Empower your strategies with our Female Sexual Dysfunction – Drugs In Development, 2024 report and make more profitable business decisions. Female sexual dysfunction occurs when a woman is not able to fully, healthily, and pleasurably experience some or all of the various physical stages the body normally experiences during sexual activity. The predisposing factors include depression or anxiety, heart and blood vessel disease, liver or kidney failure, and certain medications, such as antidepressants or high blood pressure medications. Treatment includes estrogen...
-
Product Insights
NewMenopausal Disorders – Drugs In Development, 2024
Empower your strategies with our Menopausal Disorders – Drugs In Development, 2024 report and make more profitable business decisions. Menopausal disorders encompass a range of symptoms and health issues that arise during and after menopause, a natural biological process marking the end of a woman's reproductive years. Common menopausal symptoms include hot flashes, night sweats, mood swings, and changes in sleep patterns. Hormonal fluctuations during this transition can also lead to conditions such as vaginal atrophy, affecting the genital tissues, and...
-
Product Insights
NewEndometriosis – Drugs In Development, 2024
Empower your strategies with our Endometriosis – Drugs In Development, 2024 report and make more profitable business decisions. Endometriosis is an often painful disorder in which tissue that normally lines the inside of uterus (endometrium) grows outside uterus (endometrial implant). Symptoms include pelvic pain, menstrual cramps, inflammation, infertility, and abnormal bleeding. Risk factors include age, uterine abnormalities, history of pelvic infection, and family history. Treatment includes non-steroidal anti-inflammatory drugs (NSAIDs), birth control pills, and progestins. The Endometriosis drugs in development market...
-
Product Insights
NewFemale Contraception – Drugs In Development, 2024
Empower your strategies with our Female Contraception – Drugs In Development, 2024 report and make more profitable business decisions. Contraception (birth control) prevents pregnancy by interfering with the normal process of ovulation, fertilization, and implantation. There are many contraceptive methods which include implants and injections, intrauterine devices (IUDs), pills and vaginal rings, barrier methods, sterilization, and "natural" methods. Contraception generally works by preventing sperm from reaching and fertilizing an egg (barrier and IUD methods), preventing an egg from being released every...